The Aetiological Role of Human Papillomavirus in Oesophageal Squamous Cell Carcinoma: A Meta-Analysis

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Liyanage, Surabhi S ^a   Rahman, Bayzidur ^a   Ridda, Iman ^a   Newall, Anthony T ^a   Tabrizi, Sepehr N ^b   Garland, Suzanne M ^b   Segelov, Eva ^c   Seale, Holly ^a   Crowe, Philip J ^a   Moa, Aye ^a   MacIntyre, C Raina ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ROYAL WOMEN'S HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; PAPILLOMAVIRUS INFECTION; PATHOPHYSIOLOGY; RISK FACTOR; VIRUS DETECTION;

EID: 84880821406     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069238     Document Type: Article

References (54)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
2. Curado M, Edwards B, Shin H, Storm H, Ferlay J, et al. (2007) Cancer Incidence in Five Continents. Lyon, France: IARC.
3. Syrjänen K, (2002) HPV infections and oesophageal cancer. J Clin Pathol 55: 721-728.
4. Liyanage S, Segelov E, Garland S, Tabrizi S, Seale H, et al. (2013) The Role of Human Papillomaviruses in Esophageal Squamous Cell Carcinoma. Asia Pac J Clin Oncol 9: 12-28.
5. Syrjänen K, Pyrhönen S, Aukee S, Koskela E, (1982) Squamous cell papilloma of the esophagus: a tumour probably caused by human papilloma virus (HPV). Diagn Histopathol 5: 291-296.
6. Hille J, Margolius K, Markowitz S, Isaacson C, (1986) Human papillomavirus infection related to oesophageal carcinoma in black South Africans. A preliminary study. S Afr Med J 69: 417-420.
7. Mori M, Shimono R, Inoue T, Kuwano H, Sugimachi K, et al. (1989) Papillomavirus and esophageal cancer in the Japanese and Chinese. Am J Gastroenterol 84: 1126-1127.
8. WHO IARC (2007) Smokeless Tobacco and Some Tobacco-specific N-Nitrosamines. Lyon, France: World Health Organisation and International Agency for Research on Cancer.
9. Villa L, Perez G, Kjær S, Paavonen J, Lehtinen M, et al. (2007) Prophylactic Efficacy of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Women with Virological Evidence of HPV Infection. The FUTURE II Study Group. The Journal of Infectious Diseases 196: 1438-1446.
10. Joura E, Leodolter S, Hernandez-Avila M, Wheeler C, Perez G, et al. (2007) Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three clinical trials. Lancet 369: 1693-1702.
11. Garland S, Hernandez-Avila M, Wheeler C, Perez G, Harper D, et al. (2007) Quadrivalent vaccine against Human Papillomavirus to prevent Anogenital Diseases N Engl J Med. 356: 1928-1943.
12. Rahman M, Driscoll T, Cowie C, Armstrong B (2010) Disinfection by-products in drinking water and colorectal cancer: a meta-analysis. Int J Epidemiol.
13. Hennekens C, Buring J (1987) Case-Control studies. In: Mayrent S, editor. Epidemiol Med. First ed. Boston/Toronto: Little, Brown and Company.
14. Horwitz R, Feinstein A, (1979) Methodologic standards and contradictory results in case-control research. Am J Med 66: 556-564.
15. Margetts B, Thompson R, Key T, Duffy S, Nelson M, et al. (1995) Development of a scoring system to judge the scientific quality of information from case-control and cohort studies of nutrition and disease. Nutr Cancer 24: 231-239.
16. Syrjänen K (2006) HPV and Oesophageal Carcinoma. In: Campo MS, editor. Papillomavirus Research: From Natural History to Vaccines and Beyond. Norfolk, Great Britain: Caister Academic Press. 229-253.
17. IBM. (2011) IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp.
18. StataCorp (2007) Stata Statistical Software: Release 10. College Station, TX: StataCorp LP.
19. Higgins J, Thompson S, Deeks J, Altman D, (2003) Measuring inconsistency in meta-analyses. Br J Med 327: 557-560.
20. Cao B, Tian X, Li Y, Jiang P, Ning T, et al. (2005) LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China. Carcinogenesis 26: 1280-1284.
21. Gao G-F, Roth MJ, Wei W-Q, Abnet CC, Chen F, et al. (2006) No association between HPV infection and the neoplastic progression of esophageal squamous cell carcinoma: Result from a cross-sectional study in a high-risk region of China. Int J Cancer 119: 1354-1359.
22. Egger M, Smith G, Altman D (2001) Systematic reviews in health care: meta-analysis in context. London: BMJ Publishing Group.
23. Higgins J, Green S, (editors). (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration Available from www.cochrane-handbook.org.
24. Begg C, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
25. Egger M, Smith GD, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315: 629-634.
26. Agarwal S, Chatterji A, Bhambhani S, Sharma B, (1998) Immunohistochemical co-expression of human papillomavirus type 16/18 transforming (E6) oncoprotein and p53 tumour suppressor gene proteins in oesophageal cancer. Indian J Exp Biol 36: 559-563.
27. Antonsson A, Nancarrow D, Brown I, Green A, Drew P, et al. (2010) High-Risk Human Papillomavirus in Esophageal Squamous Cell Carcinoma. Cancer Epidemiol Biomarkers Prev 19: 2080-2087.
28. Ashworth M, McDicken I, Southern S, Nash J, (1993) Human papillomavirus in squamous cell carcinoma of the oesophagus associated with tylosis. Journal Clin Pathol 46: 573-575.
29. Benamouzig R, Pigot F, Quiroga G, Validire P, Chaussade S, et al. (1992) Human papillomavirus infection in esophageal squamous-cell carcinoma in western countries. Int J Cancer 50: 549-552.
30. Cooper K, Taylor L, Govind S, (1995) Human papillomavirus DNA in oesophageal carcinomas in South Africa. J Pathol 175: 273-277.
31. Farhadi M, Tahmasebi Z, Merat S, Kamangar F, Nasrollahzadeh D, et al. (2005) Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. Gastroenterology 11: 1200-1203.
32. Fidalgo PO, Cravo ML, Chaves PP, Leitão CN, Mira FC, (1995) High prevalence of human papillomavirus in squamous cell carcinoma and matched normal esophageal mucosa. Assessment by polymerase chain reaction. Cancer 76: 1522-1528.
33. Guimaraes D, Lu S, Snijders P, Wilmotte R, Herrero R, et al. (2001) Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China. Cancer Letters 162: 231-235.
34. Khurshid A, Kazuya N, Hanae I, Manabu I, (1998) Infection of human papillomavirus (HPV) and Epstein-Barr virus (EBV) and p53 expression in human esophageal carcinoma. J Pak Med Assoc 48: 138-142.
35. Koh JS, Lee S-S, Baek HJ, Kim YI, (2008) No association of high-risk human papillomavirus with esophageal squamous cell carcinomas among Koreans, as determined by polymerase chain reaction. Dis Esophagus 21: 114-117.
36. Lambot M, Haot J, Peny M, Fayt I, Noel J, (2000) Evaluation of the role of human papillomavirus in oesophageal squamous cell carcinoma in Belgium. Acta Gastroenterol Belg 63: 154-156.
37. Lenhart D, Rifley W, Manalo P, McGregor B, (1991) Association of human papillomavirus with esophageal neoplasms. Dis Esophagus 4: 123-128.
38. Li T, Lu Z-M, Chen K-N, Guo M, Xing H-P, et al. (2001) Human papillomavirus type 16 is an important infectious factor in the high incidence of esophageal cancer in Anyang area of China. Carcinogenesis 22: 929-934.
39. Liu W, Jiang X, Zhang M, Zhang Z, (2010) The relationship between HPV16 and expression of cyclooxygenase-2, P53 and their prognostic roles in esophageal squamous cell carcinoma. Eur J Gastroenterol Hepatol 22: 67-74.
40. Lyronis I, Baritaki S, Bizakis I, Tsardi M, Spandidos D, (2005) Evaluation of the prevalence of human papillomavirus and Epstein-Barr virus in esophageal squamous cell carcinomas. Int J Biol Markers 20: 5-10.
41. Souto Damin AP, Guedes Frazzon AP, De Carvalho Damin D, Beck Biehl H, Abruzzi de Oliveira L, et al. (2006) Detection of human papillomavirus DNA in squamous cell carcinoma of the esophagus by auto-nested PCR. Dis Esophagus 19: 64-68.
42. Weston AC, Prolla JC, (2003) Association between esophageal squamous cell carcinoma and human papillomavirus detected by Hybrid Capture II assay. Dis Esophagus 16: 224-228.
43. Williamson A, Jaskiesicz K, Gunning A, (1991) The detection of human papilllomavirus in oesophageal lesions. Anticancer Res 11: 263-265.
44. Zhang D, Zhang Q, Zhou L, Huo L, Zhang Y, et al. (2010) Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16,-18 and-58 in esophageal and cervical cancer: a case-control study. BMC Cancer 10: 650-658.
45. Doll R, Hill A, (1954) The mortality of doctors in relation to their smoking habits; a preliminary report. British Medical Journal 1: 1451-1455.
46. Doll R, Hill A, (1950) Smoking and Carcinoma of the Lung. British Medical Journal 12: 739-748.
47. Friis R, Sellers T, (2009) Study Designs: Ecologic, Cross-Sectional, Case-Control. Epidemiology for Public Health Practice. Fourth ed. Sudbury, MA, USA: Jones and Bartlett Publishers LLC: 262-275.
48. Parkin D, (2006) The global health burden of infection-associated cancers in the year 2002. International Journal of Cancer 118: 3030-3044.
49. Paavonen J, Naud P, Salmerón J, Wheeler C, Chow S-N, et al. (2007) Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and pre-cancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 374: 304-314.
50. Bai S, Zhang S, Li B (1989) Primary esophageal adenocarcinoma. 11 383-385.
51. Zhang H, Chen Z, Cheng J, Zhu X, Guo W, et al. (2010) The high incidence of esophageal cancer in parts of China may result primarily from genetic rather than environmental factors. Dis Esophagus 23: 392-397.
52. Zhao P, Dai M, Chen W, Li N, (2010) Cancer trends in China. Jap J Clin Oncol 40: 281-285.
53. Department of Health and Aging. HPV Vaccination program: Available at http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/immunise-hpv (accessed 2012). Australian Government. Department of Health and Aging.
54. Syrjänen K, (2013) Geographic origin is a significant determinant of human papillomavirus prevalence in oesophageal squamous cell carcinoma: Systematic review and meta-analysis. Scandinavian Journal of Infectious Diseases 45: 1-18.